drugset
drugset / Trial / NCT02599753

Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease Patients

NCT02599753 ↗

Phase 2 Completed 35 enrolled Chang Gung Memorial Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

The objective of this protocol is to investigate the microstructural alterations and monoaminergic function in Parkinson's disease patients with impulse control disorders and cognitive impairment by multimodal MRI and 18F-DTBZ PET imaging.

Timeline

Start
2015-08
Primary completion
2018-07-31
Completion
2018-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-DTBZ Diagnostic / imaging agent 10 unknown Intravenous
Subject 18F-DTBZ Diagnostic / imaging agent 370 mbq Intravenous

Indications

Parkinson disease